tiprankstipranks
Bristol-Myers Squibb (MX:BMY)
:BMY
Mexico Market
BMY
Bristol-Myers Squibb
RESEARCH TOOLSreports

Bristol-Myers Squibb (BMY) Ratios

0 Followers

Bristol-Myers Squibb Ratios

MX:BMY's free cash flow for Q2 2026 was $0.71. For the 2026 fiscal year, MX:BMY's free cash flow was decreased by $ and operating cash flow was $0.35. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.53 1.26 1.25 1.43 1.25
Quick Ratio
 1.38 1.14 1.15 1.31 1.14
Cash Ratio
 0.47 0.44 0.44 0.51 0.42
Solvency Ratio
 0.19 0.15 <0.01 0.27 0.25
Operating Cash Flow Ratio
 0.69 0.60 0.64 0.62 0.60
Short-Term Operating Cash Flow Coverage
 12.45 6.26 7.42 4.44 3.06
Net Current Asset Value
$ -36.74B$ -42.14B$ -46.44B$ -33.90B$ -38.43B
Leverage Ratios
Debt-to-Assets Ratio
 0.49 0.52 0.55 0.44 0.42
Debt-to-Equity Ratio
 1.93 2.55 3.13 1.41 1.31
Debt-to-Capital Ratio
 0.66 0.72 0.76 0.58 0.57
Long-Term Debt-to-Capital Ratio
 0.65 0.70 0.74 0.55 0.53
Financial Leverage Ratio
 3.93 4.87 5.67 3.23 3.12
Debt Service Coverage Ratio
 5.09 3.12 0.65 4.43 3.25
Interest Coverage Ratio
 8.04 7.26 4.96 7.27 7.53
Debt to Market Cap
 0.32 0.41 0.43 0.37 0.26
Interest Debt Per Share
 21.96 24.02 26.22 20.60 19.69
Net Debt to EBITDA
 2.06 2.42 12.90 1.55 1.64
Profitability Margins
Gross Profit Margin
70.16%71.08%56.80%56.34%57.39%
EBIT Margin
27.73%23.28%-13.32%21.34%19.38%
EBITDA Margin
33.89%31.60%6.56%43.03%41.64%
Operating Profit Margin
28.27%28.48%20.00%18.82%20.08%
Pretax Profit Margin
24.21%19.35%-17.35%18.75%16.71%
Net Profit Margin
18.87%14.64%-18.53%17.83%13.71%
Continuous Operations Profit Margin
18.86%14.64%-18.49%17.86%13.75%
Net Income Per EBT
77.93%75.62%106.79%95.08%82.03%
EBT Per EBIT
85.66%67.97%-86.76%99.62%83.19%
Return on Assets (ROA)
10.59%7.83%-9.66%8.43%6.53%
Return on Equity (ROE)
46.75%38.19%-54.78%27.27%20.37%
Return on Capital Employed (ROCE)
20.16%20.60%14.03%11.62%12.37%
Return on Invested Capital (ROIC)
15.47%15.03%13.59%10.59%9.61%
Return on Tangible Assets
19.14%14.34%-18.94%17.26%16.09%
Earnings Yield
6.80%6.41%-7.80%7.56%4.13%
Efficiency Ratios
Receivables Turnover
 4.66 3.32 3.35 2.95 3.31
Payables Turnover
 3.53 3.90 5.79 6.03 6.47
Inventory Turnover
 5.36 5.18 8.16 7.38 8.41
Fixed Asset Turnover
 6.31 5.28 5.78 5.60 6.18
Asset Turnover
 0.56 0.54 0.52 0.47 0.48
Working Capital Turnover Ratio
 5.47 8.05 6.23 6.04 5.50
Cash Conversion Cycle
 42.98 86.82 90.72 112.70 97.20
Days of Sales Outstanding
 78.31 110.00 109.00 123.79 110.21
Days of Inventory Outstanding
 68.06 70.45 44.72 49.45 43.41
Days of Payables Outstanding
 103.39 93.63 63.00 60.54 56.41
Operating Cycle
 146.37 180.46 153.73 173.24 153.61
Cash Flow Ratios
Operating Cash Flow Per Share
 6.26 6.94 7.49 6.70 6.13
Free Cash Flow Per Share
 5.60 6.29 6.88 6.11 5.61
CapEx Per Share
 0.66 0.64 0.62 0.58 0.52
Free Cash Flow to Operating Cash Flow
 0.90 0.91 0.92 0.91 0.91
Dividend Paid and CapEx Coverage Ratio
 1.99 2.23 2.49 2.33 2.27
Capital Expenditure Coverage Ratio
 9.52 10.80 12.17 11.46 11.69
Operating Cash Flow Coverage Ratio
 0.30 0.30 0.30 0.33 0.32
Operating Cash Flow to Sales Ratio
 0.26 0.29 0.31 0.31 0.28
Free Cash Flow Yield
8.38%11.67%12.16%11.92%7.80%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 14.72 15.59 -12.81 13.23 24.22
Price-to-Sales (P/S) Ratio
 2.77 2.28 2.37 2.36 3.32
Price-to-Book (P/B) Ratio
 6.11 5.96 7.02 3.61 4.93
Price-to-Free Cash Flow (P/FCF) Ratio
 11.93 8.57 8.22 8.39 12.83
Price-to-Operating Cash Flow Ratio
 10.67 7.78 7.55 7.66 11.73
Price-to-Earnings Growth (PEG) Ratio
 0.18 -0.09 0.06 0.43 -4.24
Price-to-Fair Value
 6.11 5.96 7.02 3.61 4.93
Enterprise Value Multiple
 10.25 9.65 49.08 7.03 9.62
Enterprise Value
 170.89B 147.02B 155.50B 136.16B 184.85B
EV to EBITDA
 10.25 9.65 49.08 7.03 9.62
EV to Sales
 3.47 3.05 3.22 3.03 4.00
EV to Free Cash Flow
 14.94 11.45 11.15 10.76 15.47
EV to Operating Cash Flow
 13.37 10.39 10.24 9.82 14.15
Tangible Book Value Per Share
 -8.23 -10.95 -14.29 -9.26 -12.39
Shareholders’ Equity Per Share
 10.93 9.05 8.06 14.22 14.58
Tax and Other Ratios
Effective Tax Rate
 0.22 0.24 -0.07 0.05 0.18
Revenue Per Share
 24.09 23.61 23.83 21.75 21.67
Net Income Per Share
 4.55 3.46 -4.41 3.88 2.97
Tax Burden
 0.78 0.76 1.07 0.95 0.82
Interest Burden
 0.87 0.83 1.30 0.88 0.86
Research & Development to Revenue
 0.22 0.21 0.20 0.20 0.20
SG&A to Revenue
 0.15 0.15 0.16 0.00 0.00
Stock-Based Compensation to Revenue
 0.01 0.01 0.01 0.01 <0.01
Income Quality
 1.38 2.01 -1.70 1.72 2.06
Currency in USD